- Home
- MOMO vs ELVN Comparison
MOMO vs ELVN Comparison
Compare MOMO & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOMO
- ELVN
- Stock Information
- Founded
- MOMO 2011
- ELVN 2016
- Country
- MOMO China
- ELVN United States
- Employees
- MOMO N/A
- ELVN N/A
- Industry
- MOMO Computer Software: Prepackaged Software
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- MOMO Technology
- ELVN Health Care
- Exchange
- MOMO Nasdaq
- ELVN Nasdaq
- Market Cap
- MOMO 1.2B
- ELVN 1.1B
- IPO Year
- MOMO 2014
- ELVN 2020
- Fundamental
- Price
- MOMO $7.28
- ELVN $22.05
- Analyst Decision
- MOMO Buy
- ELVN Strong Buy
- Analyst Count
- MOMO 3
- ELVN 5
- Target Price
- MOMO $8.67
- ELVN $37.80
- AVG Volume (30 Days)
- MOMO 905.0K
- ELVN 221.0K
- Earning Date
- MOMO 03-13-2025
- ELVN 03-13-2025
- Dividend Yield
- MOMO 7.59%
- ELVN N/A
- EPS Growth
- MOMO N/A
- ELVN N/A
- EPS
- MOMO 0.98
- ELVN N/A
- Revenue
- MOMO $1,558,116,328.00
- ELVN N/A
- Revenue This Year
- MOMO N/A
- ELVN N/A
- Revenue Next Year
- MOMO N/A
- ELVN N/A
- P/E Ratio
- MOMO $7.38
- ELVN N/A
- Revenue Growth
- MOMO N/A
- ELVN N/A
- 52 Week Low
- MOMO $4.79
- ELVN $10.90
- 52 Week High
- MOMO $8.19
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- MOMO 54.13
- ELVN 46.81
- Support Level
- MOMO $7.04
- ELVN $21.45
- Resistance Level
- MOMO $7.36
- ELVN $22.82
- Average True Range (ATR)
- MOMO 0.24
- ELVN 1.52
- MACD
- MOMO 0.02
- ELVN 0.03
- Stochastic Oscillator
- MOMO 70.00
- ELVN 41.27
About MOMO Hello Group Inc.
Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines out of which Momo's service lines segment derives the majority of revenue.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.